Cognition is thrilled to announce that we have successfully raised $185 million in our latest funding round, a significant milestone that underscores the tremendous potential of our pioneering technology. As the makers of Devin, the world's first AI software engineer, we are at the forefront of applied AI innovation. Our mission is to develop collaborative AI teammates that empower engineering teams, allowing engineers to shift their focus from mundane coding tasks to more complex and engaging challenges. This newfound capital will accelerate our research and development efforts, enabling us to enhance Devin’s capabilities and expand our suite of end-to-end software agents to address a broader range of engineering needs. With this significant investment, we aim to foster a culture of creativity and innovation within teams, ultimately empowering them to strive for more ambitious goals. As we continue to build cutting-edge AI that integrates seamlessly with human ingenuity, we remain committed to pushing the boundaries of what’s possible in software engineering. This funding will not only support the growth of our technology but also enhance our recruitment efforts, ensuring we can attract the best talent to join our mission of transforming the engineering landscape. We extend our heartfelt gratitude to our investors for believing in our vision, and we look forward to the exciting journey ahead as we revolutionize the way software is developed. Stay tuned for more updates as we evolve and expand our capabilities to create the future of intelligent engineering!
Cognition Secures $185 Million in Series B Funding to Enhance AI Software Engineering Capabilities
Get the full Cognition company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
BioStem Technologies
BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain processing method. BioRetain has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies' quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks ("AATB"). These systems and procedures are established per current Good Tissue Practices ("cGTP") and current Good Manufacturing Processes ("cGMP"). Our portfolio of quality brands includes VENDAJE, VENDAJE AC, and VENDAJE OPTIC. Each BioStem Technologies placental allograft is processed at the Company's FDA registered and AATB accredited site in Pompano Beach, Florida.
$2.5M Unknown
today
Edify Systems
When you're running 10+ stores, the cracks in your operations become expensive. Inconsistent stock levels across sites, manual processes that don't scale, food waste that eats into margins, and zero real time visibility for the ops team. That's what Edify solves. Our AI powered platform gives operations leaders a single system to manage inventory, plan production, and report across their entire estate, whether that's 20 locations or 500. Built in intelligence surfaces the insights that matter, so your team spends less time in spreadsheets and more time running operations. What we cover: Inventory management across all sites. AI driven production planning and prep workflows. Operational reporting and real time visibility. Multi location scalability built in from day one. We work with QSR brands and multi site coffee chains who have outgrown spreadsheets and fragmented systems but need something purpose built for high volume, multi unit operations. If your back of house is holding back your growth, we should talk.
$4.0M Seed
today
Generalist
Generalist is an AI robotics company building general intelligence for the physical world. The founding team includes engineers from OpenAI, Google DeepMind, and Boston Dynamics. The company embraces both large-scale AI and robotics as core to its DNA.
$400.0M Unknown
today
Scotch
From neighborhood stores to destination warehouses, liquor retailers of all sizes have been held back by manual tasks, slow systems and limited business intelligence. So we decided to build something better — smarter software that saves time and improves margins so independent retailers could focus on their customers, not manually managing inventory.
$20.0M Series a
today
Kempfer / K Creative Office
Based in São Paulo, we specialize in social media creation and content, delivering creative solutions that connect, engage, and inspire Com sede em São Paulo, somos especialistas em criação e conteúdo para social media, entregando soluções criativas que conectam, envolvem e inspiram.
$1.3M Unknown
today
Other recent Series b rounds
Companies that recently closed a Series b round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  ONA Therapeutics Spain | Series b | $86.6M | today |
| 2 |  GR3N SA Switzerland | Series b | $15.5M | 1d ago |
| 3 |  701x United States | Series b | $10.0M | 1d ago |
| 4 |  Wordsmith AI United States | Series b | $70.0M | 1d ago |
| 5 |  MJOLNIR SPACEWORKS Japan | Series b | $11.1M | 2d ago |